Prabhakar Pitta Venkata

Statistics

Publications

Citations

406

H-Index

Active since

2019

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Mays Cancer Center at UT Health San Antonio

The University of Texas at San Antonio

Central South University

Xiangya Hospital Central South University

Prabhakar Pitta Venkata is an author at The University of Texas at San Antonio Health Science Center specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2019–2024

Publications

Acute and subacute oral toxicity of copper oxide nanoparticles in female albino Wistar rats

Lakshmi Sai Pratyusha Bugata, Prabhakar Pitta Venkata, Ananth Reddy Gundu et al. · Journal of Applied Toxicology · 2019 · 75 citations

Veterinary Medicine, Pharmacology, Toxicology +15

KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer

Mei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli et al. · Breast Cancer Research and Treatment · 2020 · 49 citations

Medicine, Oncology, Pharmacology +14

Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma

Salvador Alejo, Bridgitte E. Palacios, Prabhakar Pitta Venkata et al. · Neuro-Oncology · 2023 · 48 citations · Full text

Medicine, Molecular Biology, Oncology +17

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways

Mei Zhou, Gangadhara R. Sareddy, Mengxing Li et al. · Scientific Reports · 2019 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer

Weiwei Tang, Kumaraguruparan Ramasamy, Sureshkumar Mulampurath Achuthan Pillai et al. · Cell Death Discovery · 2021 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 13